ECT Editorial With Sensationalist Title

Out on PubMed, from 2 psychiatrists at the University of California,Riverside, is this editorial:

Should Electroconvulsive Therapy (ECT) be Banned for Schizophrenia?

Cummings MA, O'Day JA.CNS Spectr. 2021 Feb 1:1-12. doi: 10.1017/S1092852921000109. Online ahead of print.PMID: 33517952 
The pdf is here.
and from the text:
In conclusion, Read, et al identified methodological flaws in eleven studies of ECT for
depression and five related meta-analyses which evaluated 1 to 7 of these studies. Based on
their findings, they called for better-designed, more rigorous studies of ECT , as well as
immediate suspension of ECT use. While improved research and data are always a worthy goal
in medicine and psychiatry, the call for suspension of ECT use ignores decades of data
supporting the efficacy of ECT and also ignores a number of different lines of data indicating
ECT as effective in a variety of clinical circumstances, including treatment and clozapine-
resistant schizophrenia. Unlike a new and untried treatment, suspending or banning ECT in this
context would in our opinion constitute an unethical deprivation of treatment for many
patients who have few, if any, safe and viable alternatives.

This editorial, with an unfortunate sensationalist title, ends up saying the right things. Of course it would be unethical for ECT to be banned for the treatment of schizophrenia. 
It is unclear why the authors single out the schizophrenia indication for ECT.
Perhaps most unfortunately, this piece gives yet more oxygen to John Read's unhinged anti-ECT writings; they should be quickly discredited, called out for the the propaganda they are, and then forgotten.
The title of this piece, with the idea of possibly banning ECT, adds to, rather than decreases, the stigma problem facing ECT. 

Comments

  1. UnknownFebruary 24, 2021 at 10:54 PM

    That editorial has been written to strenghten the impact of mine in a special edition of CNS Spectrums. I agree with you about the choice of the title because many readers will not go further and antipsychiatrists will cite the title only.
    I asked CNS Spectrums' Editor how many italians readers downloaded our paper...The reply is yet no one. Astonishing isn't it?

    ReplyDelete

Post a Comment

Popular posts from this blog

ECT plus Antidepressants: a Review

Out on PubMed, from researchers in Rotterdam, The Netherlands, is this review: Influence of an adjuvant antidepressant on the efficacy of  electroconvulsive  therapy: A systematic review and meta-analysis. Pluijms EM, Kamperman AM, Hoogendijk WJ, Birkenhäger TK, van den Broek WW. Aust N Z J Psychiatry. 2020 Sep 8:4867420952543. doi: 10.1177/0004867420952543. Online ahead of print. PMID:  32900217 Here is the "Conclusion" section from the text: Our results suggest that an adjuvant antidepressant enhances the efficacy of ECT in patients with major depression. Although the included studies had some methodological limitations, effect sizes were consistently small to moderate. We speculate that modern-day controlled trials using adequately dosed TCAs and MAOIs will most likely result in larger effect sizes. From a clinical point of view, we prefer an adjuvant TCA to an adjuvant MAOI, since TCAs are generally safe to use with ECT ( American Psychiatric Association, 2001 ; ...
Read more

Clinical Phenotype of Behavioral-Variant Frontotemporal Dementia Reversed by ECT: A Case Report

Image
Out on PubMed, from authors in Germany, is this case report and literature review: Clinical Phenotype of Behavioral-Variant Frontotemporal Dementia Reversed by  ECT : A Case Report. Breitling B, Bartels C, Lange C, Bouter C, Falk HS, Wiltfang J, Zilles-Wegner D, Besse M. Neuropsychobiology. 2024 Dec 2:1-12. doi: 10.1159/000541668. Online ahead of print. PMID:  39622206 The abstract is copied below: Introduction: Diagnosis of frontotemporal dementia (FTD) remains difficult even in the presence of core clinical and imaging features. Furthermore, disease-modifying treatments are lacking. Case presentation: Here, we report a case of a patient with clinical and imaging features of FTD. Electroconvulsive therapy (ECT) was used to target affective and catatonic symptoms. After ECT, the patient showed improvements not only in affective symptoms but also in cognitive domains, leading to a marked improvement in the patient's level of functioning. Conclusion: Against the background of di...
Read more

Early Use of the Name "ECT"- Sacklers in 1949

Image
 "Classics in ECT" brings you this study from Creedmore State Hospital in 1949: Nonconvulsive biochemotherapy with histamine and electric convulsive therapy; a comparative study on hospitalized psychotics with a control  ECT  series. SACKLER AM, SACKLER MD, SACKLER RR. J Nerv Ment Dis. 1949 Sep;110(3):185-97. doi: 10.1097/00005053-194911030-00001. PMID:  18138865 The pdf is here . I originally choose this article as the earliest in PubMed to use the name, "ECT," although it also uses "electric [sic] convulsive therapy."  The very first PubMed "ECT" citation is from 1947, but it is written "E.C.T." and also reports a complication, so we prefer this one. Nomenclature aside, this turns out to be an interesting read, with what would now be considered a somewhat bizarre study comparing histamine therapy with ECT. Among the interesting details are the inclusion of a couple of patients with postpartum psychosis and the observation that longer ...
Read more